AI medical imaging market seen hitting $11.23 billion by 2030

The Business Research Company says AI-enabled medical imaging solutions are expanding fast, with the market forecast to rise from $2.9 billion in 2025 to $3.8 billion in 2026 and reach $11.23 billion by 2030. North America led the market in 2025 as chronic disease prevalence, hospital digitization and better AI tools drive demand.

Why it matters: - AI-enabled imaging is becoming a bigger part of how hospitals diagnose disease, with the promise of faster reads, better accuracy and more efficient clinical workflows. - The market’s projected growth points to rising demand for tools that help offset radiologist shortages and handle growing imaging volumes tied to chronic illness.

What happened: - The Business Research Company released its AI-Enabled Medical Imaging Solutions Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $2.9 billion in 2025 to $3.8 billion in 2026, a 31.2% CAGR. - The report forecasts the market will reach $11.23 billion by 2030, with a 31.1% CAGR. - North America was the largest regional market in 2025.

The details: - The report links earlier market growth to limited early adoption of AI in medical imaging, reliance on traditional analysis methods, a shortage of trained radiologists, rising chronic disease rates and early investment in imaging infrastructure. - The forecast period is expected to be driven by advances in deep learning and computer vision, more personalized diagnostics, better integration with hospital information systems, broader healthcare digitization and adoption in emerging markets. - Anticipated trends include AI-based diagnostic support tools, wider use of AI-enhanced imaging devices in hospitals, growth in multimodality imaging systems, stronger demand for workflow and management tools, and improved clinical decision accuracy and efficiency. - The report defines AI-enabled medical imaging solutions as technologies that use artificial intelligence to improve imaging processes, support diagnosis and treatment customization, streamline clinical decisions and address staffing shortages. - The company says AI helps provide faster and more reliable imaging analysis and can improve patient outcomes. - The report says chronic diseases such as cancer, diabetes, heart disease, arthritis, chronic respiratory illness, asthma and autoimmune disorders are a key growth driver because they require ongoing management and earlier detection. - The report cites World Health Organization data from September 2023 showing noncommunicable diseases cause 41 million deaths annually, or 74% of global mortality. - The WHO data also shows 17 million of those deaths occur before age 70, with cardiovascular diseases leading at 17.9 million deaths, followed by cancers, chronic respiratory diseases and diabetes. - The regional analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - New report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The report also includes key technology and future trend analysis. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests AI imaging is moving from a niche support tool toward a more standard layer in diagnostic care. - The emphasis on hospital systems integration and workflow tools suggests the next phase of adoption will depend as much on operational fit as on model performance. - North America’s lead suggests early commercialization and infrastructure maturity remain important advantages in this market.

What's next: - The report points to continued expansion through 2030 as hospitals, imaging vendors and healthcare systems add AI-driven diagnostic tools. - Emerging markets could become a larger growth engine as digitization accelerates and AI adoption broadens. - The company’s report package adds new analytics tools that may help buyers and vendors track segment opportunities and regional hot spots more closely.

The bottom line: - AI-enabled medical imaging is on a steep growth path, and chronic disease pressure plus healthcare digitization are likely to keep demand rising.